Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect

Surgery Today

Volumn 29, Issue 8, 1999, Pages 689-694

  Hosoya, Yoshinori ^a   Shibusawa, Hiroyuki ^a   Nagai, Hideo ^a   Ueno, Isao ^a   Sakuma, Kazuya ^a   Nagashima, Toru ^a   Kobayashi, Nobuhisa ^a   Kanazawa, Kyotaro ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Preoperative chemotherapy; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; THROMBOCYTOPENIA; VOMITING;

EID: 0032815106     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482310     Document Type: Article

References (24)

1. 1. Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820-1828
2. 2. Pree C, Aapro MS, Spiliopoulus A, Popowski Y, Mermillod B, Mirimanoff RO, Alberto P (1995) Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol 6:551-557
3. 3. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouim D, Boutin D, Campion JP, Launois B (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779-1784
4. 4. Japanese Society for Esophageal Disease (1992) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Kanehara, Tokyo, pp 59-93
5. 5. Miller AB, Hoogstraten B, Staquet M, Wikler A (1981) Reporting results of cancer treatment. Cancer 42:207-214
6. 6. Schlag P, Herrmann V, Raeth V, Lehner B, Schwarz V, Herfarth C (1988) Preoperative chemotherapy in esophageal cancer. A phase 2 study. Acta Oncol 27:811-814
7. 7. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60:2156-2160
8. 8. Feliu J, Gonzalez B, Garcia G, Espinosa E, Vicent JM, Gomez Navarro J, Berrocal A, Ordonez A, Vilches Y, de Castro J, Diaz J (1996) Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. Am J Clin Oncol 19:577-580
9. 9. Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DW (1996) The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 131:819-825
10. 10. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin-B, Mountain C (1992) Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 28:880-884
11. 11. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96:242-248
12. 12. Hilgenberg AD, Carey RW, Wilkins EW Jr, Choi-NC, Mathisen DJ, Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45:357-363
13. 13. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, De Besi P, Gay F, Collette L, Sahmoud T (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33:1216-1220
14. 14. Ilson D (1997) Toxicity of chemotherapy for esophageal carcinoma. Chest Surg Clin North Am 7:551-564
15. 15. Mathew G, Jamieson GG (1997) Neoadjuvant therapy for oesophageal cancer. Br J Surg 84:1185-1187
16. 16. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73:2680-2686
17. 17. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114:210-217
18. 18. Shibusawa H, Koshizuka S, Waki Y, Tuchiya I, Kobayashi N, Takazawa I, Nagashima T, Ueno I, Hosoya Y, Kanazawa K (1996) The existing stage of preoperative chemotherapy for advanced esophageal cancer in our hospital (in Japanese). Nippon Gekakeirengou Gakkai Zassi (J Jpn College Surg) 21:527
19. 19. Okuma T, Yoshioka M, Isechi S, Kondo K, Tabira Y, Torigoe Y, Miyauchi Y (1994) Preoperative chemotherapy for esophageal cancer based on chemosensitivity testing. J Thorac Cardiovasc Surg 108:823-829
20. 20. Segalin A, Ruol A, Panozzo M, Bonavina L, Bianchi LC, Peracchia A (1993) Flow cytometric DNA analysis does not predict the radiochemoresponsiveness of esophageal cancer. J Surg Oncol 54:87-90
21. 21. Lam KY, Law S, Ma LT, Ong SK, Wong J (1997) Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and P53 over espression predict chemo-responsiveness. Eur J Cancer 33:1221-1225
22. 22. Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TP (1994) Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 74:1693-1698
23. 23. Puglisi F, Di-Loreto C, Panizzo R, Avellini C, Fongione S, Cacitti V, Beltrami CA (1996) Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. J Clin Pathol 49:456-459
24. 24. Imamura M, Shimada Y, Kanda Y, Fukumoto M, Yanagibashi K, Miyahara T, Tobe T (1992) Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer. Surg Today 22:409-415